Inversely, mice treated with dysbindin-RNAi-1 or dysbindin-RNAi-2 cells presented a reduced number of metastatic tumor nodules and a heavier weight compared with those treated with dysbindin-RNAi-NC cells (Fig. 4E and 4F). This evidence concerns the gene DTNBP1 and neoplasm.